# Differential Regulation of Nav1.1 and SCN1A Disease Mutant Sodium Current Properties by Fibroblast Growth Factor Homologous Factors

**Authors:** Ashley Frazee, Agnes Zybura, Theodore R. Cummins

PMC · DOI: 10.3390/cells14040291 · Cells · 2025-02-15

## TL;DR

This study shows how FHF2A affects the behavior of Nav1.1 sodium channels and their disease-related mutations, potentially offering new insights into neurological disorders.

## Contribution

The study reveals that FHF2A differentially modulates Nav1.1 and its disease-associated mutations, a novel finding in sodium channel regulation.

## Key findings

- FHF2A induces long-term inactivation in wild-type Nav1.1 and the F1774S FHM3 mutant.
- FHF2A reduces persistent currents in the F1774S mutant, possibly rescuing its abnormal function.
- The P1894L mutation significantly reduces the effect of FHF2A on long-term inactivation.

## Abstract

Fibroblast growth factor homologous factors (FHFs) regulate the activity of several different voltage-gated sodium channels (Navs). However, more work is needed to determine how specific FHF isoforms and variants affect the properties of different Nav isoforms. In addition, it is not known if FHFs can differentially modulate the properties of Nav variants associated with disease. Here, we investigated the effects of FHF2A and FHF2B on Nav1.1 properties as well as on a familial hemiplegic migraine 3 (FHM3) causing mutation in this channel, F1774S. We found that FHF2A, but not 2B, induced prominent long-term inactivation (LTI) in the wild-type (WT) Nav1.1. Interestingly, FHF2A induced LTI in the F1774S FHM3 mutant channel to a greater extent than in the WT. Furthermore, persistent currents caused by the F1774S mutation were attenuated by the co-expression of FHF2A, leading to a possible rescue of the mutant channel phenotype. By contrast, the P1894L mutation, which is associated with epilepsy and mild intellectual disability, greatly attenuated the LTI induced by FHF2A. Overall, our data show for the first time that FHF2A might be a significant modulator of Nav1.1 that can differentially modulate the impact of Nav1.1 disease-associated mutations.

## Linked entities

- **Genes:** SCN1A (sodium voltage-gated channel alpha subunit 1) [NCBI Gene 6323], SCN1A (sodium voltage-gated channel alpha subunit 1) [NCBI Gene 6323], SCN1A (sodium voltage-gated channel alpha subunit 1) [NCBI Gene 6323]
- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** SCN1A (sodium voltage-gated channel alpha subunit 1) [NCBI Gene 6323] {aka DEE6, DEE6A, DEE6B, DRVT, EIEE6, FEB3}
- **Diseases:** intellectual disability (MESH:D008607), FHM3 (MESH:C566500), epilepsy (MESH:D004827)
- **Mutations:** F1774S, P1894L

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11853998/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11853998/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC11853998/full.md

---
Source: https://tomesphere.com/paper/PMC11853998